Table 2.

HIV-related characteristics.

	WLWH (n = 80)
Time since HIV diagnosis, years (IQR)∗	14 (7–21)
CD4 count, cells/μL (IQR)∗
Nadir	260 (163–316)
At time of analyses	592 (431–821)
CD8 T-cell count, cells/μL (IQR)	696 (553–964)
CD4/CD8 ratio	0.83 (0.61–1.16)
AIDS diagnosis†, yes (%)	12 (15)
HIV-RNA, copies/mL (IQR)	14.5 (11–30)
Time between HIV diagnosis and cART initiation, years (IQR)	4 (0–12)
cART duration, years (IQR)	6 (4–9)
Type of cART†, (%)
2NRTI+PI/r	26 (32)
2NRTI+NNRTI	30 (38)
Others	24 (30)

cART = combination anti-retroviral therapy, HIV = human immunodeficiency virus, NNRTI = non-nucleoside reverse transcriptase inhibitors, NRTI = nucleoside reverse transcriptase inhibitors, PI/r = boosted protease inhibitors, WLWH = women living with HIV.

^∗Data are presented as median and IQR (interquartile range).

^†Data are presented as absolute numbers (%).